Genentech, Inc.
$400.6M 2,544 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Midmark Corporation
Midmark Corporation reported $386,135,474.77 across General Payments, Research, and Ownership to 378 physicians and teaching hospitals across 381 transactions.
- $386.1M Top 1% payer
- All-tracks total
- 381 Above-median volume
- Transactions
- 378 Above-median reach
- Recipients
- −$6.5K
- General Payments vs PY2023
Midmark Corporation reported $386,135,474.77 across all CMS Open Payments tracks (General + Research + Ownership) to 378 physicians and teaching hospitals in Program Year 2024 - ranking #9 of 1,925 reporting manufacturers (2.8% of the all-tracks industry total); General Payments alone were $233,639.14, averaging $1.0M per recipient.
How Midmark Corporation's $386.1M all-tracks total breaks down
Midmark Corporation's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
44/100
Total payments
A
100/100
Transaction volume
F
13/100
Physician reach
F
13/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer midmark-corporation Midmark Corporation
$386.1M · #9/1,925 · 2.8% industry · PY2024
- TOT $386.1M
- RANK #9
- SHARE 2.8%
- TXN 381
- RCP 378
- CAT 4
- GEN $233.6K
- ΔGEN −$6.5K
- TOP1 3.7%
- PY 2024
Volume peers
Nearest volume peer: Genentech, Inc. ($400.6M)
Midmark Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Midmark Corporation's CMS-reported General Payments decreased by $6.5K (−2.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: MIDMARK CORPORATIONPY2023: MIDMARK CORPORATIONPY2024: Midmark Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $240,128.60
- PY2024
- $233,639.14
What the Data Shows for Midmark Corporation
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Midmark Corporation, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
Of the 4 general-payment categories charted below, "Travel and Lodging" is the largest at $213.6K across 198 transactions, 91.4% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Travel and Lodging" leads Midmark Corporation's 4-category general-payment breakdown at $213.6K, 91.4% of the reported total.
Midmark Corporation reports 4 general-payment categories - the top three are Travel and Lodging (91.4%), Food and Beverage (8.3%), and Gift (0.2%). The remaining 1 category make up 0.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Midmark Corporation divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Travel and Lodging | $213.6K | 198 | 91.4% |
| Food and Beverage | $19.4K | 173 | 8.3% |
| Gift | $565.13 | 6 | 0.2% |
| Entertainment | $24.58 | 1 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $38,366.51 (16.4%) of $233,639.14 in this company's General Payments records across 134 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Midmark Corporation
The five named recipients with the highest reported General Payments from this company
- 1
Paul Davis
$8,743.03 across 3 reported transactions
- 2
Michael Kingsley
$8,743.03 across 3 reported transactions
- 3
Jennifer Benson
$8,033.65 across 3 reported transactions
- 4
Robert Babyar
$7,738.22 across 3 reported transactions
- 5
Katie McCann
$5,108.58 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Midmark Corporation ranks #9 of 1,925 by total payments (top 1% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,624 of 1,838 by HHI (bottom 12% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Heartflow, Inc. : $1.7M total payments, HHI 157
- Globus Medical, Inc. : $27.0M total payments, HHI 156
- Saxum Surgical, Inc. : $48.5K total payments, HHI 156
- Legacy Ortho LLC : $39.6K total payments, HHI 155
- Spineart USA Inc : $830.2K total payments, HHI 154
- Medimetriks Pharmaceuticals, Inc. : $35.9K total payments, HHI 152
- Midmark Corporation (this company) : $233.6K total payments, HHI 152
- Smith+Nephew, Inc. : $46.4M total payments, HHI 151
- Dendreon Pharmaceuticals LLC : $659.8K total payments, HHI 150
- Aimmune Therapeutics, Inc. : $2.1M total payments, HHI 149
- Insmed, Inc. : $1.1M total payments, HHI 148
- Ermi LLC : $10.5K total payments, HHI 145
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Midmark Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Midmark Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Midmark Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
Janssen Research & Development, LLC
$345.1M 1,588 recipients
Compare payment profiles
AstraZeneca Pharmaceuticals LP
$428.2M 858,609 recipients
Compare payment profiles
Amgen Inc.
$343.0M 474,864 recipients
Compare payment profiles
E.R. Squibb & Sons, L.L.C.
$251.5M 236,558 recipients
Compare payment profiles
Merck Sharp & Dohme LLC
$525.2M 216,602 recipients
Compare payment profiles
Put this to use
Midmark Corporation ranks #9 of 1,925 by all-tracks total payments, led by "Travel and Lodging".
- See where Midmark Corporation sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Travel and Lodging" spend across every manufacturer, not just Midmark Corporation. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.